These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 38677534)
1. Hypoxia-induced TRPM7 promotes glycolytic metabolism and progression in hepatocellular carcinoma. Zhao F; Yu W; Hu J; Xia Y; Li Y; Liu S; Liu A; Wang C; Zhang H; Zhang L; Shi J Eur J Pharmacol; 2024 Jul; 974():176601. PubMed ID: 38677534 [TBL] [Abstract][Full Text] [Related]
2. Suppression of TRPM7 Inhibited Hypoxia-Induced Migration and Invasion of Androgen-Independent Prostate Cancer Cells by Enhancing RACK1-Mediated Degradation of HIF-1 Yang F; Cai J; Zhan H; Situ J; Li W; Mao Y; Luo Y Oxid Med Cell Longev; 2020; 2020():6724810. PubMed ID: 32215176 [TBL] [Abstract][Full Text] [Related]
3. Long non-coding RNA MAPKAPK5-AS1/PLAGL2/HIF-1α signaling loop promotes hepatocellular carcinoma progression. Wang L; Sun L; Liu R; Mo H; Niu Y; Chen T; Wang Y; Han S; Tu K; Liu Q J Exp Clin Cancer Res; 2021 Feb; 40(1):72. PubMed ID: 33596983 [TBL] [Abstract][Full Text] [Related]
4. Mild chronic hypoxia-induced HIF-2α interacts with c-MYC through competition with HIF-1α to induce hepatocellular carcinoma cell proliferation. Mu H; Yu G; Li H; Wang M; Cui Y; Zhang T; Song T; Liu C Cell Oncol (Dordr); 2021 Oct; 44(5):1151-1166. PubMed ID: 34339013 [TBL] [Abstract][Full Text] [Related]
5. In vitro and in vivo anti-metastatic effect of the alkaliod matrine from Sophora flavecens on hepatocellular carcinoma and its mechanisms. Dai M; Chen N; Li J; Tan L; Li X; Wen J; Lei L; Guo D Phytomedicine; 2021 Jul; 87():153580. PubMed ID: 34029939 [TBL] [Abstract][Full Text] [Related]
6. Hypoxia-induced UBE2K promotes the malignant progression of HCC. Ouyang G; Fu W; Guo J; Lu Q; Yao Y; Ge L; Zhao J; Zhang J; Hu X; Li S; Xu Q; Huang D; Zhang Y Pathol Res Pract; 2023 May; 245():154422. PubMed ID: 37003132 [TBL] [Abstract][Full Text] [Related]
7. HIF-1α promoted vasculogenic mimicry formation in hepatocellular carcinoma through LOXL2 up-regulation in hypoxic tumor microenvironment. Wang M; Zhao X; Zhu D; Liu T; Liang X; Liu F; Zhang Y; Dong X; Sun B J Exp Clin Cancer Res; 2017 Apr; 36(1):60. PubMed ID: 28449718 [TBL] [Abstract][Full Text] [Related]
8. Metformin suppresses hypoxia-induced stabilization of HIF-1α through reprogramming of oxygen metabolism in hepatocellular carcinoma. Zhou X; Chen J; Yi G; Deng M; Liu H; Liang M; Shi B; Fu X; Chen Y; Chen L; He Z; Wang J; Liu J Oncotarget; 2016 Jan; 7(1):873-84. PubMed ID: 26621849 [TBL] [Abstract][Full Text] [Related]
9. Yes-associated protein (YAP) binds to HIF-1α and sustains HIF-1α protein stability to promote hepatocellular carcinoma cell glycolysis under hypoxic stress. Zhang X; Li Y; Ma Y; Yang L; Wang T; Meng X; Zong Z; Sun X; Hua X; Li H J Exp Clin Cancer Res; 2018 Sep; 37(1):216. PubMed ID: 30180863 [TBL] [Abstract][Full Text] [Related]
10. Hypoxia induces epithelial-mesenchymal transition via activation of SNAI1 by hypoxia-inducible factor -1α in hepatocellular carcinoma. Zhang L; Huang G; Li X; Zhang Y; Jiang Y; Shen J; Liu J; Wang Q; Zhu J; Feng X; Dong J; Qian C BMC Cancer; 2013 Mar; 13():108. PubMed ID: 23496980 [TBL] [Abstract][Full Text] [Related]
11. HIPK2 suppresses tumor growth and progression of hepatocellular carcinoma through promoting the degradation of HIF-1α. Chen P; Duan X; Li X; Li J; Ba Q; Wang H Oncogene; 2020 Apr; 39(14):2863-2876. PubMed ID: 32034309 [TBL] [Abstract][Full Text] [Related]
12. HBXIP drives metabolic reprogramming in hepatocellular carcinoma cells via METTL3-mediated m6A modification of HIF-1α. Yang N; Wang T; Li Q; Han F; Wang Z; Zhu R; Zhou J J Cell Physiol; 2021 May; 236(5):3863-3880. PubMed ID: 33305825 [TBL] [Abstract][Full Text] [Related]
13. TRPM7 silencing modulates glucose metabolic reprogramming to inhibit the growth of ovarian cancer by enhancing AMPK activation to promote HIF-1α degradation. Chen Y; Liu L; Xia L; Wu N; Wang Y; Li H; Chen X; Zhang X; Liu Z; Zhu M; Liao Q; Wang J J Exp Clin Cancer Res; 2022 Jan; 41(1):44. PubMed ID: 35101076 [TBL] [Abstract][Full Text] [Related]
14. Sirolimus increases the anti-cancer effect of Huai Er by regulating hypoxia inducible factor-1α-mediated glycolysis in hepatocellular carcinoma. Zhou L; Zhao Y; Pan LC; Wang J; Shi XJ; Du GS; He Q World J Gastroenterol; 2022 Aug; 28(32):4600-4619. PubMed ID: 36157928 [TBL] [Abstract][Full Text] [Related]
15. Canagliflozin Modulates Hypoxia-Induced Metastasis, Angiogenesis and Glycolysis by Decreasing HIF-1α Protein Synthesis via AKT/mTOR Pathway. Luo J; Sun P; Zhang X; Lin G; Xin Q; Niu Y; Chen Y; Xu N; Zhang Y; Xie W Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948132 [TBL] [Abstract][Full Text] [Related]
16. MiR-3662 suppresses hepatocellular carcinoma growth through inhibition of HIF-1α-mediated Warburg effect. Chen Z; Zuo X; Zhang Y; Han G; Zhang L; Wu J; Wang X Cell Death Dis; 2018 May; 9(5):549. PubMed ID: 29748591 [TBL] [Abstract][Full Text] [Related]
17. Regulation of COX-2 expression and epithelial-to-mesenchymal transition by hypoxia-inducible factor-1α is associated with poor prognosis in hepatocellular carcinoma patients post TACE surgery. Huang M; Wang L; Chen J; Bai M; Zhou C; Liu S; Lin Q Int J Oncol; 2016 May; 48(5):2144-54. PubMed ID: 26984380 [TBL] [Abstract][Full Text] [Related]
18. The role of Aurora A in hypoxia-inducible factor 1α-promoting malignant phenotypes of hepatocelluar carcinoma. Cui SY; Huang JY; Chen YT; Song HZ; Huang GC; De W; Wang R; Chen LB Cell Cycle; 2013 Sep; 12(17):2849-66. PubMed ID: 23966163 [TBL] [Abstract][Full Text] [Related]
19. Hypoxia upregulates Rab11-family interacting protein 4 through HIF-1α to promote the metastasis of hepatocellular carcinoma. Hu F; Deng X; Yang X; Jin H; Gu D; Lv X; Wang C; Zhang Y; Huo X; Shen Q; Luo Q; Zhao F; Ge T; Zhao F; Chu W; Shu H; Yao M; Fan J; Qin W Oncogene; 2015 Dec; 34(49):6007-17. PubMed ID: 25745995 [TBL] [Abstract][Full Text] [Related]
20. Hypoxia-induced TUFT1 promotes the growth and metastasis of hepatocellular carcinoma by activating the Ca Dou C; Zhou Z; Xu Q; Liu Z; Zeng Y; Wang Y; Li Q; Wang L; Yang W; Liu Q; Tu K Oncogene; 2019 Feb; 38(8):1239-1255. PubMed ID: 30250300 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]